Saudi Arabia vs United Kingdom: Access to anti-retroviral drugs, male
Saudi Arabia
93.0%
in 2024
United Kingdom
93.0%
in 2023
Saudi Arabia rank
7th
United Kingdom rank
7th
Access to anti-retroviral drugs, male over time
- Saudi Arabia
- United Kingdom
How they compare
Saudi Arabia currently reports 93.0% against 93.0% in United Kingdom, a difference of 0.0%.
Across all 8 years both countries report, United Kingdom has been ahead every year.
Saudi Arabia ranks 7th and United Kingdom ranks 7th of 141 countries.
United Kingdom has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Saudi Arabia | United Kingdom | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 77.8% | 92.0% | 14.2% | United Kingdom |
| 2020s | 90.8% | 93.2% | 2.5% | United Kingdom |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, male, Saudi Arabia or United Kingdom?
- Saudi Arabia, at 93.0% against 93.0% in United Kingdom as of 2024.
- What is the difference in access to anti-retroviral drugs, male between Saudi Arabia and United Kingdom?
- 0.0%, with Saudi Arabia ahead.
- How many years of comparable data are there for Saudi Arabia and United Kingdom?
- 8 years are reported by both, from 2016 to 2023.
- How do Saudi Arabia and United Kingdom rank globally for access to anti-retroviral drugs, male?
- Saudi Arabia ranks 7th and United Kingdom ranks 7th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.